newsfilter
← Latest News
Business Wire·

Dr. Reddy's enters into collaboration with Henlius for commercialization of HLX15 (daratumumab), a biosimilar candidate to Darzalex® & Darzalex Faspro® in the U.S., and Europe

Dr. Reddy's gets exclusive rights to commercialize the subcutaneous as well as intravenous formulations of HLX15 in the U.S. and Europe Dr. Reddy's Laboratories SA, wholly-owned subsidiary of Dr. Reddy's Laboratories